These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8990259)

  • 1. Detection of intrauterine illicit drug exposure by newborn drug testing. National Academy of Clinical Biochemistry.
    Kwong TC; Ryan RM
    Clin Chem; 1997 Jan; 43(1):235-42. PubMed ID: 8990259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of toxicological research in newborn infants of addicted mothers by the study of several samples (urine, meconium, hair)].
    Sampériz S; Millet V; Arditti J; Lacroze V; Masset D; Bourdon H; Jouglard J; Unal D
    Arch Pediatr; 1996 May; 3(5):440-4. PubMed ID: 8763713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
    Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
    Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical Cord Tissue and Meconium May Not Be Equivalent for Confirming in Utero Substance Exposure.
    Colby JM; Adams BC; Morad A; Presley LD; Patrick SW
    J Pediatr; 2019 Feb; 205():277-280. PubMed ID: 30342870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses.
    DiGregorio GJ; Ferko AP; Barbieri EJ; Ruch EK; Chawla H; Keohane D; Rosenstock R; Aldano A
    J Anal Toxicol; 1994 Sep; 18(5):247-50. PubMed ID: 7990440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
    Colby JM
    Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair analysis of opiates in mothers and newborns for evaluating opiate exposure during pregnancy.
    Vinner E; Vignau J; Thibault D; Codaccioni X; Brassart C; Humbert L; Lhermitte M
    Forensic Sci Int; 2003 Apr; 133(1-2):57-62. PubMed ID: 12742690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption.
    Joya X; Marchei E; Salat-Batlle J; García-Algar O; Calvaresi V; Pacifici R; Pichini S
    Drug Test Anal; 2016 Aug; 8(8):864-8. PubMed ID: 26627903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine.
    Callahan CM; Grant TM; Phipps P; Clark G; Novack AH; Streissguth AP; Raisys VA
    J Pediatr; 1992 May; 120(5):763-8. PubMed ID: 1578314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
    Casanova OQ; Lombardero N; Behnke M; Eyler FD; Conlon M; Bertholf RL
    Arch Pathol Lab Med; 1994 Oct; 118(10):988-93. PubMed ID: 7944901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of prenatal drug exposure in the pregnant women and her newborn infant.
    Ostrea EM; Welch RA
    Clin Perinatol; 1991 Sep; 18(3):629-45. PubMed ID: 1934859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis.
    Ostrea EM
    Curr Probl Pediatr; 1999 Feb; 29(2):37-56. PubMed ID: 10021686
    [No Abstract]   [Full Text] [Related]  

  • 15. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis.
    García-Algar O; López-Vílchez MA; Martín I; Mur A; Pellegrini M; Pacifici R; Rossi S; Pichini S
    Clin Toxicol (Phila); 2007; 45(3):295-8. PubMed ID: 17453885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of drug use during pregnancy.
    Kwong TC; Shearer D
    Obstet Gynecol Clin North Am; 1998 Mar; 25(1):43-64. PubMed ID: 9547759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing.
    Labardee RM; Swartzwelder JR; Gebhardt KE; Pardi JA; Dawsey AC; Brent Dixon R; Cotten SW
    Clin Biochem; 2017 Dec; 50(18):1093-1097. PubMed ID: 28941590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Hair and Neonatal Meconium to Assess Gestational Consumption and Prenatal Exposure to Drugs of Abuse and Psychoactive Drugs.
    Cortes L; Almeida L; Sabra S; Muniesa M; Busardo FP; Garcia-Algar O; Gomez-Roig MD
    Curr Pharm Biotechnol; 2018; 19(2):136-143. PubMed ID: 29621962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.